ArticleBMC pregnancy and childbirth2025
Elective single morula transfer achieved better clinical outcomes than two cleavage embryos transfer in fresh IVF-ET cycles.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAssisted reproductive technology (ART) effectively treats infertility yet often results in multiple pregnancies. Optimizing clinical pregnancy rates while minimizing multiples remains challenging. Key considerations for ART providers include embryo transfer timing, number, and developmental stage. While double cleavage-stage and single blastocyst transfers are common, limited data exists on the intermediate strategy of single morula transfer.
objectiveThis research aimed to assess whether elective single morula transfer (eSMT) on Day 4 yields clinical outcomes comparable to double cleavage-stage embryo transfer (DCT) on Day 3.
methodsA retrospective propensity-matched cohort study compared DCT and eSMT in IVF, with 156 matched cases per group. Primary outcomes included clinical pregnancy rate (CPR), live birth rate (LBR), twin pregnancy rate, and preterm delivery rate. Secondary outcomes were abortion rate (AR) and cesarean section rate.
resultsAfter propensity score matching, no significant differences were observed between DCT and eSMT groups in CPR (75.00% vs. 69.23%), AR (16.24% vs. 14.81%), LBR (59.62% vs. 58.97%), or cesarean rate (51.61% vs. 41.30%) (all P > 0.05). The eSMT group showed significantly lower preterm delivery rates (9.78% vs. 21.51%, P < 0.05) and higher single live birth rates (58.97% vs. 43.59%, P < 0.01).
conclusionIn patients aged ≤ 35 years, Day 4 single morula transfer demonstrates clinical pregnancy rates comparable to Day 3 double cleavage-stage embryo transfer while reducing twin pregnancy and preterm labor risks, thereby providing a safe individualized treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.